Results 161 to 170 of about 13,840,459 (217)

Faricimab versus Aflibercept for Discharge and Readmission in Neovascular Age-Related Macular Degeneration: A Lesion-Type Stratified, Real-World UK Analysis. [PDF]

Clin Ophthalmol
Singh Bhangu J, Swarnkar PK, Stewart C, Rifat M, Khalid S, Al-Janabi A, Awad MH, Williams GS.   +7 more
europepmc   +1 more source

Community Optometrist-Led Monitoring of Quiescent Neovascular Age-Related Macular Degeneration: The FENETRE Randomized Clinical Trial.

JAMA Netw Open
Sharma A, Jaber A, Pal B, Lawrenson JG, Harper RA, Tufail A, Learoyd AE, Robinson E, Douiri A, Burman R, Kernohan A, Vougioukalou S, Read S, Csontos J, Jones A, Mahmood S, McKibbin M, Peacock JL, Gale R, Patel PJ, Keane PA, Hamilton R, Vale L, Bunce C, Balaskas K.   +24 more
europepmc   +1 more source

Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration. [PDF]

Pharmaceuticals (Basel)
García-Quintanilla L, Almuiña-Varela P, Rodríguez-Cid MJ, Gil-Martinez M, Abraldes MJ, Gomez-Ulla F, González-Barcia M, Castro-Fernández DC, Cañizo-Outeiriño A, Cuartero-Martínez A, Estany-Gestal A, Otero-Espinar FJ, Fernández-Rodríguez M, Fernández-Ferreiro A.   +13 more
europepmc   +1 more source

Effects of vascular endothelial growth factor and angiopoietin-2 inhibitions on intraretinal hyperreflective foci in neovascular age-related macular degeneration. [PDF]

Jpn J Ophthalmol
Nakanishi Y, Akada M, Tamiya R, Ideyama M, Kogo T, Ichioka A, Yamamoto A, Ueda-Arakawa N, Tamura H, Miyata M, Takahashi A, Kido A, Muraoka Y, Miyake M, Ooto S, Tsujikawa A, Hata M.   +16 more
europepmc   +1 more source

Effect of a Nutraceutical-Oriented Dietary Intervention on Serum Carotenoids and Antioxidant Vitamin Concentrations in Patients with Neovascular Age-Related Macular Degeneration. [PDF]

Antioxidants (Basel)
Szulim D, Kucharska E, Machalińska A, Kuprjanowicz L, Czupryński P, Szczuko M.   +5 more
europepmc   +1 more source

Patient-Reported Quality of Life and Treatment Experiences Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept in Colombia: A Qualitative Study. [PDF]

Clin Ophthalmol
Piedrahita MA, Arias-Ortiz WA, Acosta Cadavid CP, Cadena Galvis E, Peña FY.   +4 more
europepmc   +1 more source

Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration.

JAMA Ophthalmol
Pitcher JD, Koh AHC, Tan CS, Vakharia P, Dagincourt N, Patel S, Yang M, Margaron P, Gallego-Pinazo R.   +8 more
europepmc   +1 more source

Pegaptanib for Neovascular Age-Related Macular Degeneration [PDF]

New England Journal of Medicine, 2004
Pegaptanib, an anti-vascular endothelial growth factor therapy, was evaluated in the treatment of neovascular age-related macular degeneration.We conducted two concurrent, prospective, randomized, double-blind, multicenter, dose-ranging, controlled clinical trials using broad entry criteria.
Evangelos S Gragoudas, Anthony P Adamis, Emmett T Cunningham   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Neovascular Age-Related Macular Degeneration

Ophthalmologica, 2012
<i>Purpose:</i> Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an increasing incidence as the elderly population expands. Large, multi-center, randomized, clinical trials have been conducted exploring the safety and efficacy of anti-VEGF treatments. This paper aims to discuss the safety and efficacy
VERITTI, Daniele, SARAO, Valentina, LANZETTA, Paolo   +2 more
openaire   +3 more sources

Neovascular Age-Related Macular Degeneration

2015
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in individuals over the age of 50 years. Choroidal neovascularization (CNV) is the hallmark of 'wet' or 'exudative' AMD, and is responsible for approximately 90% of cases of severe vision loss due to AMD. Vascular endothelial growth factor (VEGF) is a key component in the
Jack, Shao, Maria M, Choudhary, Andrew P, Schachat   +2 more
openaire   +3 more sources